CXCR4 controls BCL-2 expression and function by regulating miR-15a/16-1 expression in tumor cells

被引：0
|
作者：
Silberman, Shiri Klein
Abraham, Michal
Bulvik, Baruch
Wald, Hanna
Eizenberg, Orly
Olam, Dvorah
Weiss, Lola
Beider, Katia
Wald, Ori
Bulvik, Shlomo
Avigdor, Abraham
Benjamini, Ohad
Galun, Eithan
Nagler, Arnon
Pereg, Yaron
Peled, Amnon
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3556
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia
    Rampazzo, Enrica
    Bojnik, Engin
    Trentin, Livio
    Bonaldi, Laura
    Del Bianco, Paola
    Frezzato, Federica
    Visentin, Andrea
    Facco, Monica
    Semenzato, Gianpietro
    De Rossi, Anita
    HAEMATOLOGICA, 2017, 102 (07) : E253 - E256
  • [32] The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
    Klein, Ulf
    Lia, Marie
    Crespo, Marta
    Siegel, Rachael
    Shen, Qiong
    Mo, Tongwei
    Ambesi-Impiombato, Alberto
    Califano, Andrea
    Migliazza, Anna
    Bhagat, Govind
    Dalla-Favera, Riccardo
    CANCER CELL, 2010, 17 (01) : 28 - 40
  • [33] CXCR4 expression in osteosarcoma cell lines and tumor samples:: Evidence for expression by tumor cells -: Response
    Laverdiere, Caroline
    Gorlick, Richard
    CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5254 - 5254
  • [34] BCL2 promotor methylation and miR-15a/16-1 upregulation is associated with sanguinarine-induced apoptotic death in rat HSC-T6 cells
    Zhang, Da-Sheng
    Li, Yuan-Yi
    Chen, Xiao-Jun
    Li, Yu-Juan
    Liu, Zhao-Ying
    Xie, Wen-Jian
    Sun, Zhi-Liang
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) : 135 - 144
  • [35] ATHEROSCLEROSIS IMPAIRS CXCR4 EXPRESSION AND FUNCTION IN BONE MARROW CELLS
    Xu Qiyuan
    Yu Hong
    HEART, 2010, 96 : A65 - A65
  • [36] Oncogenic HER2δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors
    Cittelly, Diana M.
    Das, Partha M.
    Salvo, Virgilio A.
    Fonseca, Juan P.
    Burow, Matthew E.
    Jones, Frank E.
    CARCINOGENESIS, 2010, 31 (12) : 2049 - 2057
  • [37] miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms
    Sewastianik, Tomasz
    Straubhaar, Juerg R.
    Zhao, Jian-Jun
    Samur, Mehmet K.
    Adler, Keith
    Tanton, Helen E.
    Shanmugam, Vignesh
    Nadeem, Omar
    Dennis, Peter S.
    Pillai, Vinodh
    Wang, Jianli
    Jiang, Meng
    Lin, Jianhong
    Huang, Ying
    Brooks, Daniel
    Bouxsein, Mary
    Dorfman, David M.
    Pinkus, Geraldine S.
    Robbiani, Davide F.
    Ghobrial, Irene M.
    Budnik, Bogdan
    Jarolim, Petr
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Carrasco, Ruben D.
    BLOOD, 2021, 137 (14) : 1905 - 1919
  • [38] Investigating CXCR4 expression of tumor cells and the vascular compartment: A multimodal approach
    Braga, Marta
    Leow, Chee Hau
    Gil, Javier Hernandez
    Teh, Jin H.
    Carroll, Laurence
    Long, Nicholas J.
    Tang, Meng-Xing
    Aboagye, Eric O.
    PLOS ONE, 2021, 16 (11):
  • [39] Germinal Center-Derived Lymphomas and Plasmacytomas in Mice with Targeted Deletion of MiR-15a/16-1 in Activated B Cells
    Sewastianik, Tomasz
    Zhao, Jianjun
    Jiang, Meng
    Wang, Jianli
    Pillai, Vinodh
    Dennis, Peter S.
    Lin, Jianhong
    Brooks, Daniel
    Bouxsein, Mary
    Pinkus, Geraldine S.
    Jarolim, Petr
    Robbiani, Davide
    Ghobrial, Irene M.
    Anderson, Kenneth C.
    Carrasco, Ruben D.
    BLOOD, 2016, 128 (22)
  • [40] MODIFIED MIR-15A INHIBITS ACTIVATION AND PROLIFERATION OF PANCREATIC STELLATE CELLS BY TARGETING BCL-2 AND YAP-1 IN VITRO
    Almanzar, Vanessa M. Diaz
    Shah, Kunal
    LaComb, Joseph
    Ju, Jingfang
    Bialkowska, Agnieszka B.
    GASTROENTEROLOGY, 2022, 162 (07) : S913 - S913
12345